NCT01926496 2025-03-07
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
LEO Pharma
Phase 4 Completed
LEO Pharma
Viatris Inc.
Viatris Inc.
Viatris Inc.
Viatris Inc.
Graceway Pharmaceuticals, LLC